See All Slides - tctmd.com

Slides

Presentation

Systemic vs Catheter-Directed Thrombolysis in Pulmonary Embolism

Presenter: N Patel

September 04, 2015

Presentation

Comparison of Vascular Closure Devices for Access-Site Closure After Transfemoral TAVR

Presenter: IM Barbash

September 03, 2015

Presentation ESC 2015

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

Presenter: Takeshi Kimura

September 01, 2015

Presentation ESC 2015

PLATFORM: IMpactsClinical outcomes of FFR-CT-guided diagnostic strategies versus usual care in patients with suspected coronary artery disease

Presenter: Pamela S. Douglas

September 01, 2015

Presentation ESC 2015

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Presenter: Marco Valgimigli

September 01, 2015

Presentation ESC 2015

Long-term Dual Antiplatelet Therapy for 2° Prevention of Cardiovascular Events in Patients with Previous Myocardial Infarction

Presenter: Jacob A. Udell

August 31, 2015

Presentation ESC 2015

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Presenter: G?rard Helft

August 31, 2015

Presentation ESC 2015

Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up

Presenter: Gilles Montalescot

August 30, 2015

Presentation ESC 2015

CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients?

Presenter: Michael Ovize

August 30, 2015

Presentation ESC 2015

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Presenter: Gregg W. Stone

August 30, 2015

Advertisement

Slides

Systemic vs Catheter-Directed Thrombolysis in Pulmonary Embolism

Comparison of Vascular Closure Devices for Access-Site Closure After Transfemoral TAVR

12-month clinical and 13-month angiographic outcomes from a randomized trial evaluating the Absorb Bioresorbable Vascular Scaffold vs_ metallic DES in de novo native coronary artery lesions

PLATFORM: IMpactsClinical outcomes of FFR-CT-guided diagnostic strategies versus usual care in patients with suspected coronary artery disease

Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation of Angiox-MATRIX Treatment Duration Program

Long-term Dual Antiplatelet Therapy for 2° Prevention of Cardiovascular Events in Patients with Previous Myocardial Infarction

12 vs 48 months of dual antiplatelet therapy after drug-eluting stent placement: The OPTIDUAL Randomized Trial

Aldosterone Lethal Effects Blockade in Acute Myocardial Infarction Treated With or Without Reperfusion to Improve Outcome and Survival at Six Months Follow-Up

CIRCUS Study: Does Cyclosporine Improve Clinical Outcome is ST-Elevation Myocardial Infarction Patients?

Peri-infarct Zone Pacing to Prevent Adverse Left Ventricular Remodeling in Patients with Large Myocardial Infarction: Results from the PRomPT Trial

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content